MORRISVILLE, N.C., Oct. 21, 2022 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the one totally built-in biopharmaceutical options group, will launch its third quarter 2022 monetary outcomes on Friday, November 4, 2022, previous to its earnings name at 8:00 a.m. ET.
To pay attention solely and think about the presentation slides through the reside webcast, be a part of from the Investor Relations part of the Syneos Health web site at investor.syneoshealth.com.
To take part within the convention, please register upfront at this hyperlink. Upon registration, all members will obtain a affirmation e mail detailing find out how to be a part of the convention name, together with the dial-in quantity together with a novel passcode and registrant ID that can be utilized to entry the decision.
A webcast replay might be out there on the Investor Relations part of the Syneos Health web site at investor.syneoshealth.com after 1:00 p.m. on November 4, 2022.
About Syneos Health
Syneos Health® (Nasdaq:SYNH) is the one totally built-in biopharmaceutical options group purpose-built to speed up buyer success. We lead with a product growth mindset, strategically integrating scientific growth, medical affairs and industrial capabilities to deal with fashionable market realities.
We carry collectively greater than 29,000 minds, throughout greater than 110 nations, with a deep understanding of affected person and doctor behaviors and market dynamics. Together we share insights, use the most recent applied sciences and apply superior business practices to hurry our prospects’ supply of necessary therapies to sufferers.
Syneos Health helps a various, equitable and inclusive tradition that cares for colleagues, prospects, sufferers, communities and the setting.
To study extra about how we’re Shortening the gap from lab to life®, go to syneoshealth.com or subscribe to our podcast.
